Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PRAD | rs71193952 | chr20:2141274 | A/AACACATTAGTCAAATGATC | 6.21E-6 | 473 | 27.97 | 33.18 | 28.42 | KM Plot |
PRAD | rs7122044 | chr11:72462634 | A/G | 0.000164 | 483 | 30.53 | 35.5 | 23.25 | KM Plot |
PRAD | rs7123876 | chr11:72444583 | T/C | 3.04E-5 | 485 | 29.63 | 34.82 | 21.18 | KM Plot |
PRAD | rs7125942 | chr11:68199213 | C/G | 1.61E-7 | 494 | 29.63 | 33.6 | 24.58 | KM Plot |
PRAD | rs71264538 | chr8:71950522 | TTCTC/T | 4.63E-5 | 490 | 31.03 | 29.97 | 24.27 | KM Plot |
PRAD | rs7128028 | chr11:1342819 | C/T | 1.59E-6 | 480 | 61.83 | 32.63 | 30.15 | KM Plot |
PRAD | rs71328248 | chr22:18452501 | C/A | 7.63E-8 | 481 | 30.53 | 33.07 | 26.87 | KM Plot |
PRAD | rs71329331 | chr20:2059211 | C/CA | 3.6E-7 | 490 | 28.8 | 33.6 | 29.55 | KM Plot |
PRAD | rs71359150 | chr17:2129500 | C/T | 4.52E-5 | 486 | 31 | 31.05 | 26.1 | KM Plot |
PRAD | rs71377801 | chr17:62985602 | T/C | 7.89E-9 | 489 | 30.8 | 31.37 | 19.63 | KM Plot |
PRAD | rs71377802 | chr17:62985607 | A/G | 7.89E-9 | 489 | 30.8 | 31.37 | 19.63 | KM Plot |
PRAD | rs71379903 | chr17:62985618 | C/T | 7.89E-9 | 489 | 30.8 | 31.37 | 19.63 | KM Plot |
PRAD | rs71423515 | chr2:178781157 | C/T | 4.15E-5 | 493 | 30.78 | 31.93 | 20.48 | KM Plot |
PRAD | rs71423518 | chr2:178796197 | A/C | 4.13E-5 | 494 | 30.77 | 31.93 | 20.48 | KM Plot |
PRAD | rs71423519 | chr2:178796376 | C/T | 4.13E-5 | 494 | 30.77 | 31.93 | 20.48 | KM Plot |